An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
Open Access
- 1 May 1982
- journal article
- Published by Wiley
- Vol. 13 (5) , 711-716
- https://doi.org/10.1111/j.1365-2125.1982.tb01441.x
Abstract
1 Prizidilol hydrochloride (SK&F 92657) is a new compound which causes both arteriolar dilatation and beta-adrenoceptor blockade. The effect of a single oral dose on the responses of heart rate and blood pressure to isoprenaline infusion has been studied in healthy volunteers. 2 Isoprenaline heart rate dose-response curves showed parallel shifts to the right after oral prizidilol, indicating antagonism by this compound at beta-adrenoceptors in the heart. 3 Isoprenaline dose-response curves for decreases in diastolic blood pressure also showed shifts to the right after oral prizidilol, providing evidence of beta-adrenoceptor antagonism by this drug in peripheral resistance vessels. 4 The peak effect of a 40 mg dose of propranolol was greater than that of a 200 mg dose of prizidilol but both drugs caused persistent beta-adrenoceptor blockade for at least 7 h after ingestion.Keywords
This publication has 4 references indexed in Scilit:
- Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.Published by Wiley ,1981
- Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man.Published by Wiley ,1980
- SK&F 92657, a Novel Antihypertensive Acting by Precapillary Vasodilatation and β-Adrenoreceptor BlockadeClinical Science, 1979
- The assessment of beta-adrenoceptor blocking drugs in man.Published by Wiley ,1977